IPP Bureau
Zydus receives EIR for the API manufacturing facility at Ankleshwar and Dabhasa
By IPP Bureau - June 12, 2025
Zydus receives EIR for the API manufacturing facility at Ankleshwar
Aayush Wellness to form subsidiary in Singapore to drive Southeast Asia expansion
By IPP Bureau - June 12, 2025
This strategic expansion marks a significant step in the company's global growth strategy
Boehringer Ingelheim and Eko Health collaborate to improve heart murmur detection in dogs
By IPP Bureau - June 12, 2025
The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
FDA approves Merck’s enflonsia for prevention of RSV in infants
By IPP Bureau - June 12, 2025
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
Biocon Foundation launches BioWISE Program to empower women in STEM
By IPP Bureau - June 11, 2025
25 women students to receive internship, training, and mentorship in Life Sciences segment
Lubrizol's polymer excipient Apisolex featured in Phase I candidate
By IPP Bureau - June 11, 2025
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold
Evertis selects Honeywell Aclar technology to enhance pharmaceutical packaging
By IPP Bureau - June 11, 2025
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Brenntag Specialties acquires mcePharma to cater growing demand in Biopharma market
By IPP Bureau - June 11, 2025
The acquisition sets up the foundation for a central hub of GMP value-added services and greater access to new customers in the rapidly growing Biopharma market
Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases
By IPP Bureau - June 10, 2025
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
Glenmark Pharmaceuticals to launch DCGI-approved BRUKINSA in India for treatment of hematological malignancies
By IPP Bureau - June 10, 2025
Globally, BRUKINSA is approved in more than 70 countries
Carbogen Amcis enters into a co-investment agreement of CHF 25+ million to expand Swiss sites
By IPP Bureau - June 09, 2025
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Lupin receives tentative approval from USFDA for Oxcarbazepine ER Tablets
By IPP Bureau - June 09, 2025
Oxcarbazepine ER Tablets (RLD Oxtellar XR) had estimated annual sales of US$ 206 million in the US (IQVIA MAT April 2025)
Roche’s Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
By IPP Bureau - June 09, 2025
46% reduction in the risk of disease progression or death, and 27% reduction in the risk of death, in an aggressive cancer type with limited survival and few treatment options
Health Minister Nadda delivers keynote address at FSSAI’s World Food Safety Day 2025
By IPP Bureau - June 09, 2025
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
Fujifilm rebrands life sciences companies to strengthen position as strategic partners for life
By IPP Bureau - June 07, 2025
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
